• Science Director of the European Longevity Institute.

    Biochemist, Professor of Gerontology and Biological Sciences, and Director of the Longevity Institute at the Leonard Davis School of Gerontology, University of Southern California, Los Angeles, and Director of the Oncology and Longevity Program at IFOM, Milan.

    Professor Longo earned a bachelor’s degree in biochemistry from the University of North Texas; he holds a Ph.D. in biochemistry from the University of California, Los Angeles in 1997, and completed post-doctoral training in the neurobiology of aging and Alzheimer’s disease at the University of Southern California.

    His research focuses on the analysis of multiple genetic mechanisms underlying aging and the identification of therapeutic strategies, including nutrition, to slow down or halt the onset of age-related diseases.

    Career award highlights include the 2010 Nathan Shock Lecture Award from the National Institute on Aging and the 2013 Vincent Cristofalo “Rising Star” Award for Research on Aging from the American Federation for Aging Research.

  • Romina Inés Cervigni, obtained a PhD from Open University in the United Kingdom focusing her attention on the field of oncology and a second level Masters in Nutrition and Dietetics. She has collaborated as a postdoctoral researcher with the National Research Committee (CNR) in Naples and the Vita-Salute San Raffaele University in Milan.

  • Professor, Institute of Molecular Biosciences, University of Graz, Austria.

    Professor Frank Madeo is one of the world’s most-cited scientists in the field of aging. He earned his Ph.D. in biochemistry from the University of Tübingen, Germany, in 1997, and led a research group there until 2004, when he joined the faculty of the University of Graz.An authority on apoptosis, aging and autophagy in yeast and mammals, Madeo discovered and initiated the field of programmed cell death in yeast and developed most of the techniques for its detection.

    His lab has long-standing experience in phenotyping and molecular characterization of the distinct causal metabolites of aging and longevity that are conserved across species. Madeo’s research on longevity-promoting, well​-tolerated compounds spans various model organisms, including humans.

    His recent discovery of the role of spermidine in autophagy induction, cell protection and longevity has pioneered a new and fast-growing area of research.

  • Mathematician, RAND Corporation; Professor, Pardee RAND Graduate School, Santa Monica, California

    Raffaele Vardavas earned his Ph.D. in physics from Imperial College London in 2002, and was subsequently a post-doctoral researcher at UCLA in mathematics and bio-mathematics until 2008, when he joined the RAND His expertise is primarily in constructing and analyzing epidemic models for the spread of infectious disease.

    Examples include modeling HIV transmission, projecting the impact of testing and treatment, and anticipating the emergence of multi-drug resistance.

    He also has modeled scenarios of smallpox bio-terror attacks and control policy alternatives, as well as the coupled dynamics of seasonal flu epidemics and vaccination behavior. Other research interests include modeling healthcare utilization and costs under the Affordable Care Act, modeling supply and maintenance logistics, and applying evolutionary economics to climate change policy.

  • Professor, Faculty of Medicine, University of Paris Descartes; Director, Apoptosis, Cancer and Immunity Research Team, French Medical Research Council (INSERM); Director, Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Center; Physician, Hôpital Européen George Pompidou, Paris, France; Foreign Adjunct Professor, Karolinska Institute, Stockholm, Sweden.Dr. Kroemer received his Ph.D. and M.D. degrees from the University of Innsbruck, Austria in 1985, and completed his post-doctoral training at the Collège de France, Nogent-sur-Marne. He subsequently earned a Ph.D. in molecular biology from the Autonomous University of Madrid in 1992. Prior to joining INSERM in 1994, he was a senior scientist with the European Community at the Spanish National Research Council (CSIC), the National Center of Molecular Biology, and the National Center of Biotechnology.Known for his groundbreaking work in the fields of cell biology and cancer research, Dr. Kroemer is credited with the discovery that the permeabilization of mitochondrial membranes constitutes a decisive step in programmed cell death. He has published more than 1,000 scholarly papers in top journals, including Science, Cell, and Nature.In addition to his academic appointments, he is the current director of the Paris Alliance of Cancer Research Institutes (PACRI) and LabEx Immuno-Oncology; the founding director of the European Research Institute for Integrated Cellular Pathology (ERI-ICP); and the founding president of the European Academy of Tumor Immunology (EATI).

  • Professor, Buck Institute for Research on Aging, Visiting Professor in Medicine and Healthy Aging, National University Singapore; Adjunct Professor, Davis School of Gerontology, University of Southern California; Affiliate Professor, Department of Biochemistry, University of Washington.Professor Kennedy earned his Ph.D. in biology from the Massachusetts Institute of Technology in 1996. He completed postdoctoral training at Massachusetts General Hospital’s Cancer Center and was an associate professor of biochemistry at the University of Washington in Seattle Internationally recognized for his research into the basic biology of aging, Kennedy is past president and CEO of the Buck Institute for Research on Aging. His current research focuses on the pathways that modulate longevity in life forms ranging from yeast to mice. His lab also studies cardiovascular disease and metabolic syndromes, and the genetic mutations underlying diseases such as dilated cardiomyopathy, muscular dystrophy and Hutchinson-Gilford Progeria Syndrome.